Back to search

Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.

Data up to Jan 2025

Published2001
Citations258
References27
Clinical Trials (1)

Total Citations Per Year

Abstract

References (27)

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 • 6,495 citations

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

1985 • 2,981 citations

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

1995 • 1,374 citations

Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

1990 • 926 citations

The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

1994 • 788 citations

Transcription Factors, Normal Myeloid Development, and Leukemia

1997 • 729 citations

Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.

1993 • 516 citations

Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores.

1990 • 226 citations

Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia.

1990 • 174 citations

Rescue from programmed cell death in leukemic and normal myeloid cells

1991 • 165 citations

Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.

1990 • 139 citations

AML1A and AML1B can transactivate the human IL-3 promoter.

1997 • 130 citations

Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells

1993 • 107 citations

Leukemic B-cell precursors express functional receptors for human interleukin-3

1989 • 82 citations

Cellular Responses to Interferons and Other Cytokines: The JAK–STAT Paradigm

1998 • 81 citations

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors

1992 • 78 citations

Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.

1995 • 74 citations

Impact of immunophenotyping on management of acute leukemias.

1999 • 71 citations

Autocrine growth factors and leukaemic haemopoiesis

1992 • 60 citations

Enhancement of the biologic effects of interleukin-3 in vivo by anti- interleukin-3 antibodies

1993 • 44 citations

Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells

1997 • 41 citations

Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions

2000 • 38 citations

Human recombinant IL-3 is a growth factor for normal B cells.

1992 • 34 citations

Characterization of proteins binding the 3′ regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells

1998 • 23 citations

Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo.

1988 • 20 citations

Up‐regulation of IL‐6‐receptors by IL‐3 on a plasma cell leukaemia cell line which proliferates dependently on both IL‐3 and IL‐6

1993 • 14 citations

Abnormal expression of interleukin-3 and leukaemia.

1987 • 6 citations

Cited By (0)

Loading...
Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic… (2001) – PubMed | Metascience Observatory Explorer